Global Anti-obesity Medicine Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight.
LPI (LP Information)' newest research report, the “Anti-obesity Medicine Industry Forecast” looks at past sales and reviews total world Anti-obesity Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-obesity Medicine sales for 2023 through 2029. With Anti-obesity Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-obesity Medicine industry.
This Insight Report provides a comprehensive analysis of the global Anti-obesity Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-obesity Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-obesity Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-obesity Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-obesity Medicine.
The global Anti-obesity Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-obesity Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-obesity Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-obesity Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-obesity Medicine players cover Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-obesity Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight.
LPI (LP Information)' newest research report, the “Anti-obesity Medicine Industry Forecast” looks at past sales and reviews total world Anti-obesity Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-obesity Medicine sales for 2023 through 2029. With Anti-obesity Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-obesity Medicine industry.
This Insight Report provides a comprehensive analysis of the global Anti-obesity Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-obesity Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-obesity Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-obesity Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-obesity Medicine.
The global Anti-obesity Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-obesity Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-obesity Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-obesity Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-obesity Medicine players cover Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-obesity Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Prescription Drugs
- OTC Drugs
- Men
- Women
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alizyme
- Amylin Pharmaceuticals
- Arena Pharmaceuticals
- Boehringer Ingelheim
- Eisai
- GlaxoSmithKline
- Orexigen Therapeutics
- Vivus
- Pfizer
- Roche
- Merck
- Novo Nordisk
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-obesity Medicine Market Size 2018-2029
2.1.2 Anti-obesity Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anti-obesity Medicine Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC Drugs
2.3 Anti-obesity Medicine Market Size by Type
2.3.1 Anti-obesity Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
2.4 Anti-obesity Medicine Segment by Application
2.4.1 Men
2.4.2 Women
2.5 Anti-obesity Medicine Market Size by Application
2.5.1 Anti-obesity Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
3 ANTI-OBESITY MEDICINE MARKET SIZE BY PLAYER
3.1 Anti-obesity Medicine Market Size Market Share by Players
3.1.1 Global Anti-obesity Medicine Revenue by Players (2018-2023)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Anti-obesity Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY MEDICINE BY REGIONS
4.1 Anti-obesity Medicine Market Size by Regions (2018-2023)
4.2 Americas Anti-obesity Medicine Market Size Growth (2018-2023)
4.3 APAC Anti-obesity Medicine Market Size Growth (2018-2023)
4.4 Europe Anti-obesity Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Anti-obesity Medicine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Anti-obesity Medicine Market Size by Country (2018-2023)
5.2 Americas Anti-obesity Medicine Market Size by Type (2018-2023)
5.3 Americas Anti-obesity Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-obesity Medicine Market Size by Region (2018-2023)
6.2 APAC Anti-obesity Medicine Market Size by Type (2018-2023)
6.3 APAC Anti-obesity Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-obesity Medicine by Country (2018-2023)
7.2 Europe Anti-obesity Medicine Market Size by Type (2018-2023)
7.3 Europe Anti-obesity Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-obesity Medicine by Region (2018-2023)
8.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-OBESITY MEDICINE MARKET FORECAST
10.1 Global Anti-obesity Medicine Forecast by Regions (2024-2029)
10.1.1 Global Anti-obesity Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Anti-obesity Medicine Forecast
10.1.3 APAC Anti-obesity Medicine Forecast
10.1.4 Europe Anti-obesity Medicine Forecast
10.1.5 Middle East & Africa Anti-obesity Medicine Forecast
10.2 Americas Anti-obesity Medicine Forecast by Country (2024-2029)
10.2.1 United States Anti-obesity Medicine Market Forecast
10.2.2 Canada Anti-obesity Medicine Market Forecast
10.2.3 Mexico Anti-obesity Medicine Market Forecast
10.2.4 Brazil Anti-obesity Medicine Market Forecast
10.3 APAC Anti-obesity Medicine Forecast by Region (2024-2029)
10.3.1 China Anti-obesity Medicine Market Forecast
10.3.2 Japan Anti-obesity Medicine Market Forecast
10.3.3 Korea Anti-obesity Medicine Market Forecast
10.3.4 Southeast Asia Anti-obesity Medicine Market Forecast
10.3.5 India Anti-obesity Medicine Market Forecast
10.3.6 Australia Anti-obesity Medicine Market Forecast
10.4 Europe Anti-obesity Medicine Forecast by Country (2024-2029)
10.4.1 Germany Anti-obesity Medicine Market Forecast
10.4.2 France Anti-obesity Medicine Market Forecast
10.4.3 UK Anti-obesity Medicine Market Forecast
10.4.4 Italy Anti-obesity Medicine Market Forecast
10.4.5 Russia Anti-obesity Medicine Market Forecast
10.5 Middle East & Africa Anti-obesity Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Anti-obesity Medicine Market Forecast
10.5.2 South Africa Anti-obesity Medicine Market Forecast
10.5.3 Israel Anti-obesity Medicine Market Forecast
10.5.4 Turkey Anti-obesity Medicine Market Forecast
10.5.5 GCC Countries Anti-obesity Medicine Market Forecast
10.6 Global Anti-obesity Medicine Forecast by Type (2024-2029)
10.7 Global Anti-obesity Medicine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Alizyme
11.1.1 Alizyme Company Information
11.1.2 Alizyme Anti-obesity Medicine Product Offered
11.1.3 Alizyme Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alizyme Main Business Overview
11.1.5 Alizyme Latest Developments
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Information
11.2.2 Amylin Pharmaceuticals Anti-obesity Medicine Product Offered
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amylin Pharmaceuticals Main Business Overview
11.2.5 Amylin Pharmaceuticals Latest Developments
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Information
11.3.2 Arena Pharmaceuticals Anti-obesity Medicine Product Offered
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Arena Pharmaceuticals Main Business Overview
11.3.5 Arena Pharmaceuticals Latest Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Anti-obesity Medicine Product Offered
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim Main Business Overview
11.4.5 Boehringer Ingelheim Latest Developments
11.5 Eisai
11.5.1 Eisai Company Information
11.5.2 Eisai Anti-obesity Medicine Product Offered
11.5.3 Eisai Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eisai Main Business Overview
11.5.5 Eisai Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Anti-obesity Medicine Product Offered
11.6.3 GlaxoSmithKline Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Information
11.7.2 Orexigen Therapeutics Anti-obesity Medicine Product Offered
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Orexigen Therapeutics Main Business Overview
11.7.5 Orexigen Therapeutics Latest Developments
11.8 Vivus
11.8.1 Vivus Company Information
11.8.2 Vivus Anti-obesity Medicine Product Offered
11.8.3 Vivus Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vivus Main Business Overview
11.8.5 Vivus Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Anti-obesity Medicine Product Offered
11.9.3 Pfizer Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Anti-obesity Medicine Product Offered
11.10.3 Roche Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Anti-obesity Medicine Product Offered
11.11.3 Merck Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Information
11.12.2 Novo Nordisk Anti-obesity Medicine Product Offered
11.12.3 Novo Nordisk Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Novo Nordisk Main Business Overview
11.12.5 Novo Nordisk Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-obesity Medicine Market Size 2018-2029
2.1.2 Anti-obesity Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anti-obesity Medicine Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC Drugs
2.3 Anti-obesity Medicine Market Size by Type
2.3.1 Anti-obesity Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
2.4 Anti-obesity Medicine Segment by Application
2.4.1 Men
2.4.2 Women
2.5 Anti-obesity Medicine Market Size by Application
2.5.1 Anti-obesity Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
3 ANTI-OBESITY MEDICINE MARKET SIZE BY PLAYER
3.1 Anti-obesity Medicine Market Size Market Share by Players
3.1.1 Global Anti-obesity Medicine Revenue by Players (2018-2023)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Anti-obesity Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY MEDICINE BY REGIONS
4.1 Anti-obesity Medicine Market Size by Regions (2018-2023)
4.2 Americas Anti-obesity Medicine Market Size Growth (2018-2023)
4.3 APAC Anti-obesity Medicine Market Size Growth (2018-2023)
4.4 Europe Anti-obesity Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Anti-obesity Medicine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Anti-obesity Medicine Market Size by Country (2018-2023)
5.2 Americas Anti-obesity Medicine Market Size by Type (2018-2023)
5.3 Americas Anti-obesity Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-obesity Medicine Market Size by Region (2018-2023)
6.2 APAC Anti-obesity Medicine Market Size by Type (2018-2023)
6.3 APAC Anti-obesity Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-obesity Medicine by Country (2018-2023)
7.2 Europe Anti-obesity Medicine Market Size by Type (2018-2023)
7.3 Europe Anti-obesity Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-obesity Medicine by Region (2018-2023)
8.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-OBESITY MEDICINE MARKET FORECAST
10.1 Global Anti-obesity Medicine Forecast by Regions (2024-2029)
10.1.1 Global Anti-obesity Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Anti-obesity Medicine Forecast
10.1.3 APAC Anti-obesity Medicine Forecast
10.1.4 Europe Anti-obesity Medicine Forecast
10.1.5 Middle East & Africa Anti-obesity Medicine Forecast
10.2 Americas Anti-obesity Medicine Forecast by Country (2024-2029)
10.2.1 United States Anti-obesity Medicine Market Forecast
10.2.2 Canada Anti-obesity Medicine Market Forecast
10.2.3 Mexico Anti-obesity Medicine Market Forecast
10.2.4 Brazil Anti-obesity Medicine Market Forecast
10.3 APAC Anti-obesity Medicine Forecast by Region (2024-2029)
10.3.1 China Anti-obesity Medicine Market Forecast
10.3.2 Japan Anti-obesity Medicine Market Forecast
10.3.3 Korea Anti-obesity Medicine Market Forecast
10.3.4 Southeast Asia Anti-obesity Medicine Market Forecast
10.3.5 India Anti-obesity Medicine Market Forecast
10.3.6 Australia Anti-obesity Medicine Market Forecast
10.4 Europe Anti-obesity Medicine Forecast by Country (2024-2029)
10.4.1 Germany Anti-obesity Medicine Market Forecast
10.4.2 France Anti-obesity Medicine Market Forecast
10.4.3 UK Anti-obesity Medicine Market Forecast
10.4.4 Italy Anti-obesity Medicine Market Forecast
10.4.5 Russia Anti-obesity Medicine Market Forecast
10.5 Middle East & Africa Anti-obesity Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Anti-obesity Medicine Market Forecast
10.5.2 South Africa Anti-obesity Medicine Market Forecast
10.5.3 Israel Anti-obesity Medicine Market Forecast
10.5.4 Turkey Anti-obesity Medicine Market Forecast
10.5.5 GCC Countries Anti-obesity Medicine Market Forecast
10.6 Global Anti-obesity Medicine Forecast by Type (2024-2029)
10.7 Global Anti-obesity Medicine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Alizyme
11.1.1 Alizyme Company Information
11.1.2 Alizyme Anti-obesity Medicine Product Offered
11.1.3 Alizyme Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alizyme Main Business Overview
11.1.5 Alizyme Latest Developments
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Information
11.2.2 Amylin Pharmaceuticals Anti-obesity Medicine Product Offered
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amylin Pharmaceuticals Main Business Overview
11.2.5 Amylin Pharmaceuticals Latest Developments
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Information
11.3.2 Arena Pharmaceuticals Anti-obesity Medicine Product Offered
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Arena Pharmaceuticals Main Business Overview
11.3.5 Arena Pharmaceuticals Latest Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Anti-obesity Medicine Product Offered
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim Main Business Overview
11.4.5 Boehringer Ingelheim Latest Developments
11.5 Eisai
11.5.1 Eisai Company Information
11.5.2 Eisai Anti-obesity Medicine Product Offered
11.5.3 Eisai Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eisai Main Business Overview
11.5.5 Eisai Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Anti-obesity Medicine Product Offered
11.6.3 GlaxoSmithKline Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Information
11.7.2 Orexigen Therapeutics Anti-obesity Medicine Product Offered
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Orexigen Therapeutics Main Business Overview
11.7.5 Orexigen Therapeutics Latest Developments
11.8 Vivus
11.8.1 Vivus Company Information
11.8.2 Vivus Anti-obesity Medicine Product Offered
11.8.3 Vivus Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vivus Main Business Overview
11.8.5 Vivus Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Anti-obesity Medicine Product Offered
11.9.3 Pfizer Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Anti-obesity Medicine Product Offered
11.10.3 Roche Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Anti-obesity Medicine Product Offered
11.11.3 Merck Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Information
11.12.2 Novo Nordisk Anti-obesity Medicine Product Offered
11.12.3 Novo Nordisk Anti-obesity Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Novo Nordisk Main Business Overview
11.12.5 Novo Nordisk Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-obesity Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Prescription Drugs
Table 3. Major Players of OTC Drugs
Table 4. Anti-obesity Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 7. Anti-obesity Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 10. Global Anti-obesity Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Anti-obesity Medicine Revenue Market Share by Player (2018-2023)
Table 12. Anti-obesity Medicine Key Players Head office and Products Offered
Table 13. Anti-obesity Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Anti-obesity Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Anti-obesity Medicine Market Size Market Share by Regions (2018-2023)
Table 18. Global Anti-obesity Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Anti-obesity Medicine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Anti-obesity Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Anti-obesity Medicine Market Size Market Share by Country (2018-2023)
Table 22. Americas Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 24. Americas Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 26. APAC Anti-obesity Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Anti-obesity Medicine Market Size Market Share by Region (2018-2023)
Table 28. APAC Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 30. APAC Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 32. Europe Anti-obesity Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Anti-obesity Medicine Market Size Market Share by Country (2018-2023)
Table 34. Europe Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 36. Europe Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Anti-obesity Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Anti-obesity Medicine
Table 45. Key Market Challenges & Risks of Anti-obesity Medicine
Table 46. Key Industry Trends of Anti-obesity Medicine
Table 47. Global Anti-obesity Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Anti-obesity Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Anti-obesity Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Anti-obesity Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Alizyme Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 52. Alizyme Anti-obesity Medicine Product Offered
Table 53. Alizyme Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Alizyme Main Business
Table 55. Alizyme Latest Developments
Table 56. Amylin Pharmaceuticals Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 57. Amylin Pharmaceuticals Anti-obesity Medicine Product Offered
Table 58. Amylin Pharmaceuticals Main Business
Table 59. Amylin Pharmaceuticals Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Amylin Pharmaceuticals Latest Developments
Table 61. Arena Pharmaceuticals Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 62. Arena Pharmaceuticals Anti-obesity Medicine Product Offered
Table 63. Arena Pharmaceuticals Main Business
Table 64. Arena Pharmaceuticals Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Arena Pharmaceuticals Latest Developments
Table 66. Boehringer Ingelheim Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 67. Boehringer Ingelheim Anti-obesity Medicine Product Offered
Table 68. Boehringer Ingelheim Main Business
Table 69. Boehringer Ingelheim Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Boehringer Ingelheim Latest Developments
Table 71. Eisai Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 72. Eisai Anti-obesity Medicine Product Offered
Table 73. Eisai Main Business
Table 74. Eisai Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Eisai Latest Developments
Table 76. GlaxoSmithKline Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 77. GlaxoSmithKline Anti-obesity Medicine Product Offered
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. GlaxoSmithKline Latest Developments
Table 81. Orexigen Therapeutics Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 82. Orexigen Therapeutics Anti-obesity Medicine Product Offered
Table 83. Orexigen Therapeutics Main Business
Table 84. Orexigen Therapeutics Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Orexigen Therapeutics Latest Developments
Table 86. Vivus Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 87. Vivus Anti-obesity Medicine Product Offered
Table 88. Vivus Main Business
Table 89. Vivus Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Vivus Latest Developments
Table 91. Pfizer Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 92. Pfizer Anti-obesity Medicine Product Offered
Table 93. Pfizer Main Business
Table 94. Pfizer Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer Latest Developments
Table 96. Roche Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 97. Roche Anti-obesity Medicine Product Offered
Table 98. Roche Main Business
Table 99. Roche Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Roche Latest Developments
Table 101. Merck Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 102. Merck Anti-obesity Medicine Product Offered
Table 103. Merck Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. Novo Nordisk Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 107. Novo Nordisk Anti-obesity Medicine Product Offered
Table 108. Novo Nordisk Main Business
Table 109. Novo Nordisk Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Novo Nordisk Latest Developments
Table 1. Anti-obesity Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Prescription Drugs
Table 3. Major Players of OTC Drugs
Table 4. Anti-obesity Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 7. Anti-obesity Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 10. Global Anti-obesity Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Anti-obesity Medicine Revenue Market Share by Player (2018-2023)
Table 12. Anti-obesity Medicine Key Players Head office and Products Offered
Table 13. Anti-obesity Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Anti-obesity Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Anti-obesity Medicine Market Size Market Share by Regions (2018-2023)
Table 18. Global Anti-obesity Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Anti-obesity Medicine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Anti-obesity Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Anti-obesity Medicine Market Size Market Share by Country (2018-2023)
Table 22. Americas Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 24. Americas Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 26. APAC Anti-obesity Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Anti-obesity Medicine Market Size Market Share by Region (2018-2023)
Table 28. APAC Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 30. APAC Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 32. Europe Anti-obesity Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Anti-obesity Medicine Market Size Market Share by Country (2018-2023)
Table 34. Europe Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 36. Europe Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Anti-obesity Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Anti-obesity Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Anti-obesity Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Anti-obesity Medicine
Table 45. Key Market Challenges & Risks of Anti-obesity Medicine
Table 46. Key Industry Trends of Anti-obesity Medicine
Table 47. Global Anti-obesity Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Anti-obesity Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Anti-obesity Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Anti-obesity Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Alizyme Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 52. Alizyme Anti-obesity Medicine Product Offered
Table 53. Alizyme Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Alizyme Main Business
Table 55. Alizyme Latest Developments
Table 56. Amylin Pharmaceuticals Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 57. Amylin Pharmaceuticals Anti-obesity Medicine Product Offered
Table 58. Amylin Pharmaceuticals Main Business
Table 59. Amylin Pharmaceuticals Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Amylin Pharmaceuticals Latest Developments
Table 61. Arena Pharmaceuticals Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 62. Arena Pharmaceuticals Anti-obesity Medicine Product Offered
Table 63. Arena Pharmaceuticals Main Business
Table 64. Arena Pharmaceuticals Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Arena Pharmaceuticals Latest Developments
Table 66. Boehringer Ingelheim Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 67. Boehringer Ingelheim Anti-obesity Medicine Product Offered
Table 68. Boehringer Ingelheim Main Business
Table 69. Boehringer Ingelheim Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Boehringer Ingelheim Latest Developments
Table 71. Eisai Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 72. Eisai Anti-obesity Medicine Product Offered
Table 73. Eisai Main Business
Table 74. Eisai Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Eisai Latest Developments
Table 76. GlaxoSmithKline Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 77. GlaxoSmithKline Anti-obesity Medicine Product Offered
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. GlaxoSmithKline Latest Developments
Table 81. Orexigen Therapeutics Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 82. Orexigen Therapeutics Anti-obesity Medicine Product Offered
Table 83. Orexigen Therapeutics Main Business
Table 84. Orexigen Therapeutics Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Orexigen Therapeutics Latest Developments
Table 86. Vivus Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 87. Vivus Anti-obesity Medicine Product Offered
Table 88. Vivus Main Business
Table 89. Vivus Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Vivus Latest Developments
Table 91. Pfizer Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 92. Pfizer Anti-obesity Medicine Product Offered
Table 93. Pfizer Main Business
Table 94. Pfizer Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer Latest Developments
Table 96. Roche Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 97. Roche Anti-obesity Medicine Product Offered
Table 98. Roche Main Business
Table 99. Roche Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Roche Latest Developments
Table 101. Merck Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 102. Merck Anti-obesity Medicine Product Offered
Table 103. Merck Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. Novo Nordisk Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
Table 107. Novo Nordisk Anti-obesity Medicine Product Offered
Table 108. Novo Nordisk Main Business
Table 109. Novo Nordisk Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Novo Nordisk Latest Developments
LIST OF FIGURES
Figure 1. Anti-obesity Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-obesity Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anti-obesity Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anti-obesity Medicine Sales Market Share by Country/Region (2022)
Figure 8. Anti-obesity Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anti-obesity Medicine Market Size Market Share by Type in 2022
Figure 10. Anti-obesity Medicine in Men
Figure 11. Global Anti-obesity Medicine Market: Men (2018-2023) & ($ Millions)
Figure 12. Anti-obesity Medicine in Women
Figure 13. Global Anti-obesity Medicine Market: Women (2018-2023) & ($ Millions)
Figure 14. Global Anti-obesity Medicine Market Size Market Share by Application in 2022
Figure 15. Global Anti-obesity Medicine Revenue Market Share by Player in 2022
Figure 16. Global Anti-obesity Medicine Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 18. APAC Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 19. Europe Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 21. Americas Anti-obesity Medicine Value Market Share by Country in 2022
Figure 22. United States Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Anti-obesity Medicine Market Size Market Share by Region in 2022
Figure 27. APAC Anti-obesity Medicine Market Size Market Share by Type in 2022
Figure 28. APAC Anti-obesity Medicine Market Size Market Share by Application in 2022
Figure 29. China Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Anti-obesity Medicine Market Size Market Share by Country in 2022
Figure 36. Europe Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Figure 37. Europe Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Figure 38. Germany Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 52. APAC Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 53. Europe Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 55. United States Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 56. Canada Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 59. China Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 60. Japan Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 61. Korea Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 63. India Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Australia Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 65. Germany Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 66. France Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 67. UK Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Italy Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 69. Russia Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Spain Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 73. Israel Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 76. Global Anti-obesity Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Anti-obesity Medicine Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Anti-obesity Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-obesity Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anti-obesity Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anti-obesity Medicine Sales Market Share by Country/Region (2022)
Figure 8. Anti-obesity Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anti-obesity Medicine Market Size Market Share by Type in 2022
Figure 10. Anti-obesity Medicine in Men
Figure 11. Global Anti-obesity Medicine Market: Men (2018-2023) & ($ Millions)
Figure 12. Anti-obesity Medicine in Women
Figure 13. Global Anti-obesity Medicine Market: Women (2018-2023) & ($ Millions)
Figure 14. Global Anti-obesity Medicine Market Size Market Share by Application in 2022
Figure 15. Global Anti-obesity Medicine Revenue Market Share by Player in 2022
Figure 16. Global Anti-obesity Medicine Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 18. APAC Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 19. Europe Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Anti-obesity Medicine Market Size 2018-2023 ($ Millions)
Figure 21. Americas Anti-obesity Medicine Value Market Share by Country in 2022
Figure 22. United States Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Anti-obesity Medicine Market Size Market Share by Region in 2022
Figure 27. APAC Anti-obesity Medicine Market Size Market Share by Type in 2022
Figure 28. APAC Anti-obesity Medicine Market Size Market Share by Application in 2022
Figure 29. China Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Anti-obesity Medicine Market Size Market Share by Country in 2022
Figure 36. Europe Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Figure 37. Europe Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Figure 38. Germany Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Anti-obesity Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 52. APAC Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 53. Europe Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 55. United States Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 56. Canada Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 59. China Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 60. Japan Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 61. Korea Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 63. India Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Australia Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 65. Germany Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 66. France Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 67. UK Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Italy Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 69. Russia Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Spain Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 73. Israel Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Anti-obesity Medicine Market Size 2024-2029 ($ Millions)
Figure 76. Global Anti-obesity Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Anti-obesity Medicine Market Size Market Share Forecast by Application (2024-2029)
